NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Katanosin B and Plusbacin A3: Inhibitors of Cell Wall Synthesis in Methicillin-Resistant Staphylococcus aureus.

MAKI H, MIURA K, YAMANO Y, SHIMADA J, KUWAHARA S; Interscience Conference on Antimicrobial Agents and Chemotherapy.

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 1999 Sep 26-29; 39: 329 (abstract no. 1273).

Discov. Res. Labs., Shionogi & Co. Ltd., Toyonaka, JAPAN

Katanosin B and plusbacin A3 are naturally occurring cyclic depsipeptide antibiotics, which are active against methicillin-resistant Staphylococcus aureus and VanA-type vancomycin-resistant enterococci with MIC ranging from 0.39 to 1.56 microg/ml. Both antibitics have been reported to be inhibitors of cell wall synthesis on the basis of their inhibiting the incorporation of radio-labeled diaminopimelic acid into the cell wall peptidoglycan of bacilli. In the present study, the mechanism of action was further elucidated with using the target organism and vancomycin as a comparator. Both antibiotics were examined for effects on peptidoglycan biosynthesis, using the particulate enzymes prepared from S. aureus SRM133, a laboratory mutant with enhanced activity of peptidoglycan formation. The effects on accumulation of lipid intermediate and of nascent peptidoglycan were examined by incorporation of radio-labeled substrates detected on thin layer chromatography. Both antibiotics inhibited the formation of nascent peptidoglycan at several times lower concentrations than that of vancomycin. Both antibiotics also inhibited the formation of lipid intermediate, although needed a few times higher concentrations compared to transglycosylation inhibition. While the accumulation of lipid intermediates was not curtailed by excess of vancomycin, as noted in literature. The antibacterial activity of both antibiotics against vancomycin-resistant enterococci might be explained by blocking transglycosylation and its foregoing steps of cell wall synthesis.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Anti-Bacterial Agents
  • Cell Wall
  • Depsipeptides
  • Enterococcus
  • Microbial Sensitivity Tests
  • Peptidoglycan
  • Staphylococcus aureus
  • Vancomycin
  • Vancomycin Resistance
  • chemical synthesis
  • immunology
  • katanosin B
  • plusbacin A3
Other ID:
  • GWAIDS0009155
UI: 102246652

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov